The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study

Objective: Soy and cocoa have been suggested to be beneficial for diabetes. The aim of this study was to identify the effects of soy protein, isoflavones, and cocoa on glycemic control parameters.Research design and methods: The study was a parallel, double-blind, placebo-controlled study where pati...

Full description

Bibliographic Details
Main Authors: Judit Konya, Thozhukat Sathyapalan, Eric S. Kilpatrick, Stephen L. Atkin
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00296/full
_version_ 1819093204396408832
author Judit Konya
Thozhukat Sathyapalan
Eric S. Kilpatrick
Stephen L. Atkin
author_facet Judit Konya
Thozhukat Sathyapalan
Eric S. Kilpatrick
Stephen L. Atkin
author_sort Judit Konya
collection DOAJ
description Objective: Soy and cocoa have been suggested to be beneficial for diabetes. The aim of this study was to identify the effects of soy protein, isoflavones, and cocoa on glycemic control parameters.Research design and methods: The study was a parallel, double-blind, placebo-controlled study where patients with diet or metformin controlled type 2 diabetes were randomized to, casein soy protein with or without isoflavones (SPI, SP), and with or without cocoa (SPIC, SPC) arms for an 8 week period. Glycemic control and cardiovascular risk factors were assessed prior to and after the completion of the dietary intervention. Sixty participants completed the study.Results: Soy protein improved HbA1c compared to casein (p < 0.05). The addition of isoflavones improved indices of insulin resistance and LDL [delta QUICKIE (SPI: −0.12 ± 0.04 vs. SP: 0.03 ± 0.06, p = 0.03); delta LDL (−0.27 ± 0.41 vs. 0.22 ± 0.43, p = 0.02); percentage change in HOMA (31.02 ± 54.75 vs. −14.42 ± 27.07, p = 0.02); percentage change in QUICKIE (−3.89 ± 7.07 vs. 6.11 ± 10.54, p = 0.01)]. However, the addition of cocoa provided no benefit with or without isoflavones.Summary: Soy protein had intrinsic activity on glycemic control compared to casein. Isoflavones improved both insulin resistance and LDL, but cocoa did not have added benefit on these indices.Clinical Trial Registration:www.ClinicalTrials.gov, identifier NCT01754662.
first_indexed 2024-12-21T23:07:48Z
format Article
id doaj.art-295f6bf8e5d445f1abe2178cae28b998
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-21T23:07:48Z
publishDate 2019-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-295f6bf8e5d445f1abe2178cae28b9982022-12-21T18:47:07ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922019-05-011010.3389/fendo.2019.00296435213The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled StudyJudit Konya0Thozhukat Sathyapalan1Eric S. Kilpatrick2Stephen L. Atkin3Diabetes Research Centre, University of Hull, Kingston upon Hull, United KingdomDiabetes Research Centre, University of Hull, Kingston upon Hull, United KingdomSidra Research Centre, Doha, QatarWeill Cornell Medicine, Doha, QatarObjective: Soy and cocoa have been suggested to be beneficial for diabetes. The aim of this study was to identify the effects of soy protein, isoflavones, and cocoa on glycemic control parameters.Research design and methods: The study was a parallel, double-blind, placebo-controlled study where patients with diet or metformin controlled type 2 diabetes were randomized to, casein soy protein with or without isoflavones (SPI, SP), and with or without cocoa (SPIC, SPC) arms for an 8 week period. Glycemic control and cardiovascular risk factors were assessed prior to and after the completion of the dietary intervention. Sixty participants completed the study.Results: Soy protein improved HbA1c compared to casein (p < 0.05). The addition of isoflavones improved indices of insulin resistance and LDL [delta QUICKIE (SPI: −0.12 ± 0.04 vs. SP: 0.03 ± 0.06, p = 0.03); delta LDL (−0.27 ± 0.41 vs. 0.22 ± 0.43, p = 0.02); percentage change in HOMA (31.02 ± 54.75 vs. −14.42 ± 27.07, p = 0.02); percentage change in QUICKIE (−3.89 ± 7.07 vs. 6.11 ± 10.54, p = 0.01)]. However, the addition of cocoa provided no benefit with or without isoflavones.Summary: Soy protein had intrinsic activity on glycemic control compared to casein. Isoflavones improved both insulin resistance and LDL, but cocoa did not have added benefit on these indices.Clinical Trial Registration:www.ClinicalTrials.gov, identifier NCT01754662.https://www.frontiersin.org/article/10.3389/fendo.2019.00296/fulltype 2 diabetessoycocoaglycemia controlisoflavones
spellingShingle Judit Konya
Thozhukat Sathyapalan
Eric S. Kilpatrick
Stephen L. Atkin
The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
Frontiers in Endocrinology
type 2 diabetes
soy
cocoa
glycemia control
isoflavones
title The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_full The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_fullStr The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_full_unstemmed The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_short The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_sort effects of soy protein and cocoa with or without isoflavones on glycemic control in type 2 diabetes a double blind randomized placebo controlled study
topic type 2 diabetes
soy
cocoa
glycemia control
isoflavones
url https://www.frontiersin.org/article/10.3389/fendo.2019.00296/full
work_keys_str_mv AT juditkonya theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT thozhukatsathyapalan theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT ericskilpatrick theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT stephenlatkin theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT juditkonya effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT thozhukatsathyapalan effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT ericskilpatrick effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT stephenlatkin effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy